Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-041904
Filing Date
2021-08-06
Accepted
2021-08-06 07:18:28
Documents
69
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q imra-10q_20210630.htm   iXBRL 10-Q 2672199
2 EX-31.1 imra-ex311_10.htm EX-31.1 20742
3 EX-31.2 imra-ex312_7.htm EX-31.2 20971
4 EX-32.1 imra-ex321_9.htm EX-32.1 9846
5 EX-32.2 imra-ex322_6.htm EX-32.2 10040
  Complete submission text file 0001564590-21-041904.txt   7736261

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA imra-20210630.xsd EX-101.SCH 49349
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imra-20210630_cal.xml EX-101.CAL 44977
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imra-20210630_def.xml EX-101.DEF 150320
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE imra-20210630_lab.xml EX-101.LAB 387769
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imra-20210630_pre.xml EX-101.PRE 301487
11 EXTRACTED XBRL INSTANCE DOCUMENT imra-10q_20210630_htm.xml XML 1117544
Mailing Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116 617-206-2020
IMARA Inc. (Filer) CIK: 0001672619 (see all company filings)

EIN.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39247 | Film No.: 211150543
SIC: 2834 Pharmaceutical Preparations